ЛИТЕРАТУРА

28. Hardin J. Light chain restriction confined to lower portions of cutaneous lymphocytic proliferations: a potential diagnostic pitfall / J. Hardin, B. Barrows, J. Duff, et al // J Cutan Pathol. 2014. Vol. 41. N. 12. P. 978–980.

29. Kempf W. Cutaneous lymphomas: an update. Part 2: B-cell lymphomas and related conditions / W. Kempf, D. Kazakov, C. Mitteldorf // Am J. Dermatopathol. 2014. Vol. 36. N. 3. P. 197–208. doi: 10.1097/DAD.0b013e318289b20e.

30. Kempf W. Pathologic Diagnosis of Cutaneous Lymphomas / W. Kempf, C. Mitteldorf // Dermatol Clin. 2015. Vol. 33. N. 4. P. 655–681. doi: 10.1016/j.det.2015.05.002.

31. Kempf W. Cutaneous lymphomas-An update 2019 / W. Kempf, A. Zimmermann, C. Mitteldorf // Hematol Oncol. 2019. Vol. 37. P. 43–47. doi: 10.1002/hon.2584.

32. Khelifa E. Cutaneous pseudolymphomas after leech therapy / E. Khelifa, G. Kaya, E. Laffitte // J. Dermatol. 2013. Vol. 40. N. 8. P. 674–675. doi: 10.1111/1346-8138.12198.

33. Kimura Y. Pathologic significance of immunoglobulin G4-positive plasma cells in extrahepatic cholangiocarcinoma / Y. Kimura, K. Harada, Y. Nakanuma // Hum. Pathol. 2012. Vol. 43. P. 2149–2156.

34. Kluger N. Cutaneous lymphoid hyperplasia (pseudolymphoma) in tattoos: a case series of seven patients / N. Kluger, C. Vermeulen, P. Moguelet, H. Cotten, M. Koeb, B. Balme, T. Fusade // J Eur Acad Dermatol Venereol. 2010. Vol. 24. N. 2. P. 208–213. doi: 10.1111/j.1468-3083.2009.03305.x.

35. Koh W. Cutaneous pseudolymphoma occurring after traumatic implantation of a foreign red pigment / W. Koh, Y. Tay, M. Koh, C. Sim // Singapore Med J. 2013. Vol. 54. N. 5. P. 100–101. doi: 10.11622/smedj.2013063.

36. Kokovic I. Diagnostic value of immunoglobulin κ light chain gene rearrangement analysis in B-cell lymphomas / I. Kokovic, B. Jezersek Novakovic, S. Novakovic // Int J Oncol. 2015. Vol. 46. N. 3. P. 953–62. doi: 10.3892/ijo.2014.2790.

37. Koneczny I. Update on IgG4-mediated autoimmune diseases: New insights and new family members / I. Koneczny // Autoimmun Rev. 2020. Vol. 19. N. 10. P. 102646. doi: 10.1016/j.autrev.2020.102646.

38. Kuflik A. Lymphocytoma cutis: a series of five patients successfully treated with cryosurgery / A. Kuflik, R. Schwartz // J. Am Acad Dermatol. 1992. Vol. 26. P. 449–452.

39. Kulow B. Progression of cutaneous B-cell pseudolymphoma to cutaneous B-cell lymphoma / B. Kulow, H. Cualing, P. Steele, J. VanHorn, J. Breneman, D. Mutasim, et al // J Cutan Med Surg. 2002. Vol. 6. N. 6. P. 519–528. doi: 10.1007/s10227-001-0133-7.

40. Langerak A. EuroClonality / BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations / P. Groenen, M. Bruggemann et al. // Leukemia. 2012. Vol. 26. P. 2159–2171.

41. Lanzillotta, M. Advances in the diagnosis and management of IgG4 related disease / M. Lanzillotta, G. Mancuso, E. Della-Torre // BMJ. 2020. Vol. 369. e1067. doi: 10.1136/bmj.m1067.

42. LeBoit P. Cutaneous lymphocytic infiltrates / P. LeBoit // Am J. Dermatopathol. 2005. Vol. 27. P. 182–184.

43. Lever W. Histopathology of the skin. 4th ed. / W. Lever. London and Philadelphia, 1967. P. 736–767.

44. Olisova O. Yu. Efficacy of chlorine photodynamic therapy in cutaneous lymphoid hyperplasia / O. Yu. Olisova, E.M. Anpilogova // Dermatol Ther. 2020. Vol. 33. N. 6. e13938. doi: 10.1111/dth.13938.

45. Olsen T. Angiolymphoid hyperplasia with eosinophilia: a clinicopathologic study of 116 patients / T. Olsen, E. Helwig // J. Am Acad Dermatol. 1985. Vol. 12. P. 781–796.

46. O'Neill J. ALA-PDT for the treatment of cutaneous pseudolymphoma: a case report / J. O’Neill, S. Fien, N. Zeitouni // J Drugs Dermatol. 2010. Vol. 9. N. 6. P. 688–689.

47. Ono S. Proposal of inducible skin-associated lymphoid tissue (iSALT) / S. Ono, K. Kabashima // Exp Dermatol. 2015. Vol. 24. N. 8. P. 630–1. doi: 10.1111/exd.12716.

48. Ortonne N. Granuloma faciale: a clinicopathologic study of 66 patients / N. Ortonne, J. Wechsler, M. Bagot, E. Grosshans, B. Cribier // J. Am Acad Dermatol. 2005. Vol. 53. P. 1002–1009.

49. Poopak B. PCR Analysis of IgH and TCR-γ Gene Rearrangements as a Confirmatory Diagnostic Tool for Lymphoproliferative Disorders / B. Poopak, A. Valeshabad, F. Elahi, H. Rezvani, G. Khosravipour, M. Jahangirpour et al // Indian J Hematol Blood Transfus. 2015. Vol. 31. N. 1. P. 38–45. doi: 10.1007/s12288-014-0387-z.

50. Qia G. Is the step-up therapy of topical 5- aminolevulinic acid photodynamic therapy effective and safe for the patients with recalcitrant facial flat wart? / G. Qian, S. Wang, D. Deng, G. Yang // Dermatologic therapy. 2014. Vol. 27. N. 2. P. 83–88.

51. Radic M. Tracking and trapping somatic mutations in Ig genes / M. Radic // J. Immunol. 2008. Vol. 180. P. 5763–5764.

52. Rezk M. Cutaneous pseudolymphomas: inflammatory reactive proliferations / M. Rezk, A. Hussein // Expert Rev Hematol. 2013. Vol. 6. N. 6. P. 713–733. doi: 10.1586/17474086.2013.845000.

53. Rice J. Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review / J. Rice, A. White, L. Scarpati, G. Wan, W. Nelson // Clin Ther. 2017. Vol. 39. N. 11. P. 2216–2229. doi: 10.1016/j.clinthera.2017.09.011.

54. Rijlaarsdam J. Cutaneous immunocytomas: A clinicopathologic study of 26 cases / J. Rijlaarsdam, S. Van der Putte, E. Berti et al // Histopathology. 1993. Vol. 23. P. 117–125.

55. Rijlaarsdam U. Demonstration of clonal immunoglobulin gene rearrangements in cutaneous B-cell lymphomas and pseudo-B-cell lymphomas: differential diagnostic and pathogenetic aspects / U. Rijlaarsdam, V. Bakels, J. van Oostveen, R. Gordijn, M. Geerts, C. Meijer, R. Willemze // J. Invest Dermatol. 1992. Vol. 99. N. 6. P. 749–754. doi: 10.1111/1523-1747.ep12614479.

56. Ritter J. Assessment of clonality in cutaneous lymphoid infiltrates by polymerase chain reaction analysis of immunoglobulin heavy chain gene rearrangement / J. Ritter, M. Wick, P. Adesokan, J. Fitzgibbon, X. Zhu, P. Humphrey // Am J. Clin Pathol. 1997. Vol. 108. N. 1. P. 60–68.

57. Romero-Pérez D. Cutaneous Pseudolymphomas / D. Romero-Pérez, M. Blanes Martínez, B. Encabo-Durán // Actas Dermosifiliogr. 2016. Vol. 107. N. 8. P. 640–651. doi: 10.1016/j.ad.2016.05.003.

58. Schafernak K. Clonality assessment of cutaneous B-cell lymphoid proliferations: a comparison of flow cytometry immunophenotyping, molecular studies, and immunohistochemistry/in situ hybridization and review of the literature / K. Schafernak, D. Variakojis, C. Goolsby et al // Am J. Dermatopathol. 2014. Vol. 36. N. 10. P. 781–795.

59. Singletary H. Subcutaneous interferon alfa for the treatment of cutaneous pseudolymphoma / H. Singletary, M. Selim, E. Olsen // Arc Dermatol. 2012. Vol. 148. P. 572–574.

60. Sinkora M. Ig Light Chain Precedes Heavy Chain Gene Rearrangement during Development of B Cells in Swine / M. Sinkora, J. Sinkorova, K. Stepanova // J. Immunol. 2017. Vol. 198. P. 1543–1552.

61. Skala S. Primary Cutaneous Follicle Center Lymphoma / S. Skala, B. Hristov, A. Hristov // Arch Pathol Lab Med. 2018. Vol. 142. N. 11. P. 1313–1321. doi: 10.5858/arpa.2018-0215-RA.

62. Steinbauer J. Photodynamic therapy in dermatology / J. Steinbauer, S. Schreml, E. Kohl, S. Karrer, M. Landthaler, R. Szeimies // J Dtsch Dermatol Ges. 2010. Vol. 8. N. 6. P. 454–464. doi: 10.1111/j.1610-0387.2010.07343.x.

63. Takeda H. Successful treatment of lymphadenosis benigna cutis with topical photodynamic therapy with delta-aminolevulinic acid / H. Takeda, T. Kaneko, K. Harada, Y. Matsuzaki, H. Nakano, K. Hanada // Dermatology. 2005. Vol. 211. N. 3. P. 264–266.

64. Tan S. The role of chemokines in cutaneous immunosurveillance / S. Tan, B. Roediger, W. Weninger // Immunol Cell Biol. 2015. Vol. 93. N. 4. P. 337–346. doi: 10.1038/icb.2015.16.

65. Taylor R. Radiation therapy for B-cell cutaneous lymphoid hyperplasia / R. Taylor, J. Fortney, R. Pollack, J. Metcalf, J. Jenrette // Jpn. J. Radiol. 2010. 28. N. 5. P. 385–387. DOI: 10.1007/s11604-010- 0439-8.

66. Temiz S. Cutaneous Pseudolymphoma Due to Hirudotherapy / S. Temiz, I. Özer, A. Ataseven, R. Dursun, S. Fındık // Turkiye Parazitol Derg. 2019. Vol. 43. N. 1. P. 50–52. doi: 10.4274/tpd.galenos.2018.6037.

67. Van Hale H. Nodular lymphoid disease of the head and neck: lymphocytoma cutis, benign lymphocytic infiltrate of Jessner, and their, and their distinction from malignant lymphoma / H. van Hale, R. Winkelmann // J. Am Acad Dermatol. 1985. Vol. 12. P. 455–461.

68. Venkataraman G. Marginal zone lymphomas involving meningeal dura: possible link to IgG4-related diseases / G. Venkataraman, K. Rizzo, J. Chavez, B. Streubel, M. Raffeld, E. Jaffe, S. Pittaluga // Mod Pathol. 2011. Vol. 24. N. 3. P. 355–366.

69. Vitiello P. Primary Cutaneous B-Cell Lymphomas: An Update / P. Vitiello, A. Sica, A. Ronchi, S. Caccavale, R. Franco, G. Argenziano // Front Oncol. 2020. Vol. 10. P. 651. doi: 10.3389/fonc.2020.00651.

70. Wang H. An immune evasion mechanism with IgG4 playing an essential role in cancer and implication for immunotherapy / H. Wang, Q. Xu, C. Zhao, Z. Zhu, X. Zhu, J. Zhou // J. Immunother Cancer. 2020. Vol. 8. N. 2. e000661. doi: 10.1136/jitc-2020-000661.

71. Watanabe R. Lymphocytoma cutis due to pierced earrings / R. Watanabe, H. Nanko, S. Fukuda // J. Cutan Pathol. 2006. Vol. 33. N. 2. P. 16–19. doi: 10.1111/j.1600-0560.2006.00522.x.

72. Waugh E. Optimisation and validation of a PCR for antigen receptor rearrangement (PARR) assay to detect clonality in canine lymphoid malignancies / E. Waugh, A. Gallagher, H. Haining et al. // Vet Immunol Immunopathol. 2016. Vol. 182. P. 115–124.

73. Wilcox R. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management / R. Wilcox // Am J. Hematol. 2018. Vol. 93. N. 11. P. 1427–1430. doi: 10.1002/ajh.25224.

74. Willemze R. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas / R. Willemze, L. Cerroni, W. Kempf, E. Berti, F. Facchetti, S. Swerdlow et al. // Blood. 2019. Vol. 133. N. 16. P. 1703–1714. doi: 10.1182/blood-2018-11-881268.

75. Willemze R. Primary cutaneous large cell lymphomas of follicular center cell origin / R. Willemze, C.J. Meijer, H. Sentis, et al. // J Am AcadDermatol. 1987. Vol. 16. N. 3. P. 518–526.

76. Williams D.M. Clinical Pharmacology of Corticosteroids / D.M. Williams // Respir Care. 2018. Vol. 63. N. 6. P. 655–670. doi: 10.4187/respcare.06314.

77. Wood G.S. Clonal rearrangements of immunoglobulin genes and progression to B cell lymphoma in cutaneous lymphoid hyperplasia / G.S. Wood, B.Y. Ngan, R. Tung, T.E. Hoffman, E.A. Abel, R.T. Hoppe et al // Am J. Pathol. 1989. Vol. 135. P. 13–19.

78. Yao J. Significance of detecting IgH, TCRgamma gene rearrangements in patients with hemopoietic maligancies by real-time quantitative PCR / J. Yao, R.H. Wang, B. Li, Y. Wang, P. Zhu, X.J. Li, et al // Genet Mol Res. 2015. Vol. 14: P. 12168–12177.

79. Yazdi A.S. Laser-capture microdissection: applications in routine molecular dermatopathology / A.S. Yazdi, U. Puchta, M.J. Flaig, C.A. Sander // J. Cutan Pathol. 2004. Vol. 31. P. 465–470

80. Yüksel M. Cutaneous pseudolymphoma presenting with multiple giant lesions: A case report / M. Yüksel, M. Ozdemir, A. Balevi, I. Türkmen, C. Demirkesen // Dermatol Ther. 2020. Vol. 33. N. 6. e14251. doi: 10.1111/dth.14251.

81. Zeng S.H. A case of cutaneous pseudolymphoma with a distinctive appearance treated successfully by intralesional interferon alpha-1b and corticosteroids / S.H. Zeng, S.Y. Chen, X.Y. Tang, L. Wang // Dermatol Ther. 2020. Vol. 33. N. 3. e13410. doi: 10.1111/dth.13410.

82. Zhou L.L. Cutaneous lymphoid hyperplasia (pseudolymphoma) / L.L. Zhou, N. Mistry // CMAJ. 2018. Vol. 190. N. 13. e398. doi: 10.1503/cmaj.170812.

83. Zuberbier T. Use of topical steroids is largely restricted by irrational emotional concerns in both patients and physicians / T. Zuberbier, M. Maurer, M. Augustin // Allergy. 2008. Vol. 63. N. 11. P. 1560–1561.